v Vasyl
on

 

Hi there,

Is there a time schedule for when Pinnacle21 plans to support SDTM IG 3.4 validation?

Thank you!

Vasyl

Forums: SDTM

Sergiy
on April 8, 2022

Hi, 

A scope for Community Validator is to support regulatory submissions. So far, none of regulatory agencies (FDA, PMDA, NMPA) accepts SDTMIG 3.4.

Also, our industry metrics show that today most studies still utilize SDTMIG 3.2. There are 10 times less studies based on SDTMIG 3.3 compare to v3.2.

We are introducing support for SDTMIG 3.4 as beta version in Enterprise only. Plans for Community are still open and driven by FDA, PMDA and NMPA.

Could you explain why do you need SDTMIG 3.4 now? Are you planning some submission? Do you need some new domains or variables introduced in SDTMIG 3.4?

Kind Regards,
Sergiy 

j Joan
on January 17, 2024

Hi Sergiy,

Is there a time schedule for when Pinnacle21 Community plans to support SDTM IG 3.4 validation, now it is accepted by the FDA? The requirement of this version will be started on 1year and 2months.

Thank you.

Kind regards,

Joan

j Jozef
on February 4, 2024

Dear Joan,

Did you ever get an answer to your question?
We do already (for a longer time) fully support SDTMIG-3.4 in all our products.

Matt
on February 5, 2024

Hello Joan,

 

The P21 validation engine, available in our Enterprise product, has had support for SDTMIG 3.4 validations. We recently released the FDA 2304.3 engine to support SDTMIG 3.4 validations following the FDA beginning support for SDTMIG 3.4 back in December. Speaking with our team, they let me know that the FDA 2304.3 engine is going to be available within Community in the next few weeks.

 

Kind regards,

Matt

k Kishore
on April 4, 2024

Hi Matt and Sergiy,

 

Do we have any update on when we will be able to validate against SDTM IG V 3.4 and ADaM V 1.2/1.3 on the P21 community version?

 

Thanks,

Kishore

Want a demo?

Let’s Talk.

We're eager to share and ready to listen.

Cookie Policy

Pinnacle 21 uses cookies to make our site easier for you to use. By continuing to use this website, you agree to our use of cookies. For more info visit our Privacy Policy.